Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Accepts healthy volunteers

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age

ClinicalTrials.gov ID: NCT07365826

Public ClinicalTrials.gov record NCT07365826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 Concomitantly Administered With Seasonal Influenza Vaccine in Healthy Subjects 50 Years of Age and Older

Study identification

NCT ID
NCT07365826
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vaxcyte, Inc.
Industry
Enrollment
1,390 participants

Conditions and interventions

Interventions

  • 31-valent pneumococcal conjugate vaccine Biological
  • Placebo Biological
  • Seasonal Influenza Vaccine (SIV) (Flublok) Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2026
Primary completion
Feb 28, 2027
Completion
Feb 28, 2027
Last update posted
May 14, 2026

2026 – 2027

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Hope Research Institute Phoenix Arizona 85032
Tekton Research at Fort Collins Fort Collins Colorado 80525
University Clinical Research - Deland DeLand Florida 32720-0834
CenExel Research Centers of America Hollywood Florida 33024
Health Awareness Jupiter Florida 33458
Accel Research Sites - Lakeland Lakeland Florida 33803
Accel Research Sites - Largo Largo Florida 33777
Precision Clinical Research Sunrise Florida 33351
Velocity Valparaiso Valparaiso Indiana 46383
Johnson County ClinTrials Lenexa Kansas 66219
AMR Lexington Lexington Kentucky 40509
DM Clinical Research - Detroit Detroit Michigan 48076
Velocity Omaha Omaha Nebraska 68134
Rochester Clinical Research Rochester New York 14609
CTI Clinical Research Center Cincinnati Ohio 45212
Coastal Carolina Research Center North Charleston South Carolina 29405
DelRicht Research - Hendersonville Hendersonville Tennessee 37075
AMR Knxoville Knoxville Tennessee 37909
Tekton Research at Austin Austin Texas 78745
REX Clinical Trials Beaumont Texas 77701
Epic Medical Research DeSoto Texas 75115
CenExel JBR Clinical Research Salt Lake City Utah 84107
Charlottesville Medical Research Center Charlottesville Virginia 22911
Health Research of Hampton Roads, Inc. Newport News Virginia 23606
Clinical Research Partners, LLC. Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07365826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07365826 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →